Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IPG-1094 by Immunophage Biotech for Multiple Myeloma (Kahler Disease): Likelihood of Approval
IPG-1094 is under clinical development by Immunophage Biotech and currently in Phase I for Multiple Myeloma (Kahler Disease). According to...
IPG-1094 by Immunophage Biotech for Systemic Lupus Erythematosus: Likelihood of Approval
IPG-1094 is under clinical development by Immunophage Biotech and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData,...
IPG-1094 by Immunophage Biotech for Psoriasis: Likelihood of Approval
IPG-1094 is under clinical development by Immunophage Biotech and currently in Phase I for Psoriasis. According to GlobalData, Phase I...
IPG-1094 by Immunophage Biotech for Multiple Sclerosis: Likelihood of Approval
IPG-1094 is under clinical development by Immunophage Biotech and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase...